StockData
Kamada Ltd logo

Kamada Ltd (KMDA) stock

KMDANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 11, 2026Score 5/30
$8.09−0.04 (-0.49%)

Close on Nov 13, 2026Market cap $466.68MP/E –Yield –

Kamada enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Kamada's enterprise value was $404.02M on Apr 30, 2026, against $244.66M a year earlier. Over the last 5 years it ranged from $134.65M to $436.32M, with a median of $211.52M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Apr 30, 2026$404.02M+33.0%
2025Apr 30, 2025$303.80M+17.1%
2024Apr 30, 2024$259.40M+35.1%
2023Apr 28, 2023$192.07M-21.5%
2022Apr 29, 2022$244.66M+81.7%
2021Jul 30, 2021$134.65M-36.1%
2020Dec 31, 2020$210.80M-18.4%
2019Dec 31, 2019$258.26M+35.1%
2018Dec 31, 2018$191.23M+15.7%
2017Dec 29, 2017$165.21M-14.2%
2016Dec 30, 2016$192.49M–

More Kamada figures

See a number that looks wrong?